One in eight women has it. Seventy percent never get diagnosed. They get sent to a dermatologist for the acne, an internist for the blood sugar, a psychiatrist for the anxiety, and nobody connects the three. Yemi Famuyiwa, an OB/GYN and infertility specialist, explains why polycystic ovary syndrome just got renamed, why the old name kept patients away from the care they needed, and what should raise your antenna in a primary care visit.

⏱️ Chapters:
0:00 Introduction
0:27 Why the new name came out of nowhere
1:26 The old name fragmented care for decades
2:01 The word that scared patients away from treatment
3:06 There are no cysts in polycystic ovary syndrome
3:40 What a jammed conveyor belt explains about the ovary
5:41 Four specialists, four treatments, one missed disease
8:02 One in eight women, and 70 percent go undiagnosed
8:31 What should raise your antenna in primary care
8:58 The blood test that is now diagnostic
11:03 What patients should ask their doctor to connect
11:34 The androgen exposure that reaches the fetus
13:05 Take home messages

About this episode:
Yemi Famuyiwa is an OB/GYN and infertility specialist who sees polycystic ovary syndrome from the vantage point of a reproductive endocrinologist, often the last stop after a patient has already been through three or four other specialists. She explains that the international consensus decision to rename the condition polymetabolic endocrine ovarian syndrome confirmed what fertility physicians had long known, that the disease was never confined to the ovaries. The old name, she argues, caused real harm: patients assumed a purely gynecologic problem and stopped worrying about diabetes and cardiac risk, radiologists diagnosed it off a string of pearls on ultrasound alone, and care fragmented into silos that never spoke to each other. She walks through the biology with a conveyor belt analogy, explaining that the so-called cysts are simply normal follicles backed up behind a stalled process, and that cyst only means fluid-filled, not cancerous or tumorous. She lays out the numbers, one in eight women and roughly 170 million people worldwide, with 70 percent of diagnoses missed, then maps the specialist-by-specialist path a patient takes through dermatology, internal medicine, hepatology, and psychiatry without anyone naming the underlying syndrome. For primary care, she describes the constellation that should raise suspicion and explains why AMH is now part of the diagnostic picture, including how the threshold shifts with age. She also previews a finding she covers later in her four-part series, that elevated maternal androgens cross the placenta and affect the developing fetal ovary. Her closing advice to patients is direct: if your periods are irregular and the symptoms are stacking up, find a physician who will put the whole picture together.

🤝 Partner with me on the KevinMD platform:
With over three million monthly readers and half a million social media followers, I give you direct access to the doctors and patients who matter most. Let's work together to tell your story.

➡️ PARTNER WITH KEVINMD: https://kevinmd.com/influencer
➡️ SUBSCRIBE TO THE PODCAST: https://www.kevinmd.com/podcast
➡️ RECOMMENDED BY KEVINMD: https://www.kevinmd.com/recommended

#PCOS #WomensHealth #OBGYN